The NF-KB Inhibitor LC-1 Has Single Agent Activity in Multiple Myeloma Cells and Synergizes with Bortezomib

EJ Walsby, Guy Pratt, S Hewamana, PA Crooks, AK Burnett, C Fegan, C Pepper

Research output: Contribution to journalArticle

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The NF-KB Inhibitor LC-1 Has Single Agent Activity in Multiple Myeloma Cells and Synergizes with Bortezomib'. Together they form a unique fingerprint.

Medicine & Life Sciences